Orion Portfolio Solutions LLC Sells 985 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Orion Portfolio Solutions LLC cut its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 3.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 29,880 shares of the company’s stock after selling 985 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in VanEck Pharmaceutical ETF were worth $2,578,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. bought a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter valued at $29,000. Activest Wealth Management bought a new position in VanEck Pharmaceutical ETF during the fourth quarter valued at about $32,000. Tidemark LLC lifted its position in shares of VanEck Pharmaceutical ETF by 123.6% in the fourth quarter. Tidemark LLC now owns 1,183 shares of the company’s stock worth $102,000 after buying an additional 654 shares during the last quarter. FMR LLC boosted its stake in shares of VanEck Pharmaceutical ETF by 12.5% during the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock worth $181,000 after acquiring an additional 212 shares in the last quarter. Finally, Grimes & Company Inc. acquired a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter valued at about $310,000.

VanEck Pharmaceutical ETF Stock Performance

Shares of PPH stock opened at $88.73 on Wednesday. The company has a market capitalization of $553.68 million, a price-to-earnings ratio of 27.82 and a beta of 0.72. The stock’s 50 day simple moving average is $90.90 and its 200 day simple moving average is $90.60. VanEck Pharmaceutical ETF has a twelve month low of $84.48 and a twelve month high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 4th. Investors of record on Tuesday, April 1st will be issued a dividend of $0.5245 per share. This is an increase from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. This represents a $2.10 annualized dividend and a dividend yield of 2.36%. The ex-dividend date of this dividend is Tuesday, April 1st.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.